17-β-Estradiol decreases p38 MAPK-mediated myocardial inflammation and dysfunction following acute ischemia

Meijing Wang, Ben M. Tsai, Karen M. Reiger, John Brown, Daniel R. Meldrum

Research output: Contribution to journalArticle

80 Citations (Scopus)

Abstract

Understanding the inflammatory response to myocardial ischemia is an important part of achieving the elusive clinical goal of perfect myocardial protection. While it is established that estrogen affects the chronic inflammatory processes of coronary atherosclerosis, the effects of estrogen on acute myocardial proinflammatory signaling are unknown. To study this, myocardial ischemia and reperfusion was performed in rat hearts from normal adult males, normal adult females, ovariectomized (OVX) females, males supplemented with E2, and OVX females supplemented with E2. Following reperfusion, homogenized hearts were analyzed for TNF-α, IL-1β, and IL-6 gene and protein expression, p38 MAPK activation, and the apoptosis-related proteins caspase-3 and Bcl-2. Hearts from proestrus females demonstrated significantly better post-ischemic functional recovery than males. E2 supplementation to males and OVX females improved post-ischemic myocardial functional recovery, reduced the production of TNF-α, IL-1β and IL-6, and decreased the activation of p38 MAPK and caspase-3 when compared to their untreated counterparts. These results suggest that the effect of estrogen on cardioprotection against myocardial I/R may be attributed to its anti-inflammatory and anti-apoptotic properties. Further understanding of these mechanisms may allow therapeutic manipulation of sex hormones in the treatment of acute ischemic injury.

Original languageEnglish
Pages (from-to)205-212
Number of pages8
JournalJournal of Molecular and Cellular Cardiology
Volume40
Issue number2
DOIs
StatePublished - Feb 2006

Fingerprint

p38 Mitogen-Activated Protein Kinases
Estradiol
Ischemia
Inflammation
Estrogens
Interleukin-1
Caspase 3
Myocardial Ischemia
Interleukin-6
Proestrus
Myocardial Reperfusion
Gonadal Steroid Hormones
Reperfusion
Coronary Artery Disease
Proteins
Anti-Inflammatory Agents
Apoptosis
Gene Expression
Wounds and Injuries

Keywords

  • Estrogen
  • Gender
  • Ischemia
  • Myocardium
  • p38 MAPK
  • Sex

ASJC Scopus subject areas

  • Molecular Biology
  • Cardiology and Cardiovascular Medicine

Cite this

17-β-Estradiol decreases p38 MAPK-mediated myocardial inflammation and dysfunction following acute ischemia. / Wang, Meijing; Tsai, Ben M.; Reiger, Karen M.; Brown, John; Meldrum, Daniel R.

In: Journal of Molecular and Cellular Cardiology, Vol. 40, No. 2, 02.2006, p. 205-212.

Research output: Contribution to journalArticle

@article{2b8b4decfb394778bf99939dac324198,
title = "17-β-Estradiol decreases p38 MAPK-mediated myocardial inflammation and dysfunction following acute ischemia",
abstract = "Understanding the inflammatory response to myocardial ischemia is an important part of achieving the elusive clinical goal of perfect myocardial protection. While it is established that estrogen affects the chronic inflammatory processes of coronary atherosclerosis, the effects of estrogen on acute myocardial proinflammatory signaling are unknown. To study this, myocardial ischemia and reperfusion was performed in rat hearts from normal adult males, normal adult females, ovariectomized (OVX) females, males supplemented with E2, and OVX females supplemented with E2. Following reperfusion, homogenized hearts were analyzed for TNF-α, IL-1β, and IL-6 gene and protein expression, p38 MAPK activation, and the apoptosis-related proteins caspase-3 and Bcl-2. Hearts from proestrus females demonstrated significantly better post-ischemic functional recovery than males. E2 supplementation to males and OVX females improved post-ischemic myocardial functional recovery, reduced the production of TNF-α, IL-1β and IL-6, and decreased the activation of p38 MAPK and caspase-3 when compared to their untreated counterparts. These results suggest that the effect of estrogen on cardioprotection against myocardial I/R may be attributed to its anti-inflammatory and anti-apoptotic properties. Further understanding of these mechanisms may allow therapeutic manipulation of sex hormones in the treatment of acute ischemic injury.",
keywords = "Estrogen, Gender, Ischemia, Myocardium, p38 MAPK, Sex",
author = "Meijing Wang and Tsai, {Ben M.} and Reiger, {Karen M.} and John Brown and Meldrum, {Daniel R.}",
year = "2006",
month = "2",
doi = "10.1016/j.yjmcc.2005.06.019",
language = "English",
volume = "40",
pages = "205--212",
journal = "Journal of Molecular and Cellular Cardiology",
issn = "0022-2828",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - 17-β-Estradiol decreases p38 MAPK-mediated myocardial inflammation and dysfunction following acute ischemia

AU - Wang, Meijing

AU - Tsai, Ben M.

AU - Reiger, Karen M.

AU - Brown, John

AU - Meldrum, Daniel R.

PY - 2006/2

Y1 - 2006/2

N2 - Understanding the inflammatory response to myocardial ischemia is an important part of achieving the elusive clinical goal of perfect myocardial protection. While it is established that estrogen affects the chronic inflammatory processes of coronary atherosclerosis, the effects of estrogen on acute myocardial proinflammatory signaling are unknown. To study this, myocardial ischemia and reperfusion was performed in rat hearts from normal adult males, normal adult females, ovariectomized (OVX) females, males supplemented with E2, and OVX females supplemented with E2. Following reperfusion, homogenized hearts were analyzed for TNF-α, IL-1β, and IL-6 gene and protein expression, p38 MAPK activation, and the apoptosis-related proteins caspase-3 and Bcl-2. Hearts from proestrus females demonstrated significantly better post-ischemic functional recovery than males. E2 supplementation to males and OVX females improved post-ischemic myocardial functional recovery, reduced the production of TNF-α, IL-1β and IL-6, and decreased the activation of p38 MAPK and caspase-3 when compared to their untreated counterparts. These results suggest that the effect of estrogen on cardioprotection against myocardial I/R may be attributed to its anti-inflammatory and anti-apoptotic properties. Further understanding of these mechanisms may allow therapeutic manipulation of sex hormones in the treatment of acute ischemic injury.

AB - Understanding the inflammatory response to myocardial ischemia is an important part of achieving the elusive clinical goal of perfect myocardial protection. While it is established that estrogen affects the chronic inflammatory processes of coronary atherosclerosis, the effects of estrogen on acute myocardial proinflammatory signaling are unknown. To study this, myocardial ischemia and reperfusion was performed in rat hearts from normal adult males, normal adult females, ovariectomized (OVX) females, males supplemented with E2, and OVX females supplemented with E2. Following reperfusion, homogenized hearts were analyzed for TNF-α, IL-1β, and IL-6 gene and protein expression, p38 MAPK activation, and the apoptosis-related proteins caspase-3 and Bcl-2. Hearts from proestrus females demonstrated significantly better post-ischemic functional recovery than males. E2 supplementation to males and OVX females improved post-ischemic myocardial functional recovery, reduced the production of TNF-α, IL-1β and IL-6, and decreased the activation of p38 MAPK and caspase-3 when compared to their untreated counterparts. These results suggest that the effect of estrogen on cardioprotection against myocardial I/R may be attributed to its anti-inflammatory and anti-apoptotic properties. Further understanding of these mechanisms may allow therapeutic manipulation of sex hormones in the treatment of acute ischemic injury.

KW - Estrogen

KW - Gender

KW - Ischemia

KW - Myocardium

KW - p38 MAPK

KW - Sex

UR - http://www.scopus.com/inward/record.url?scp=31444455757&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=31444455757&partnerID=8YFLogxK

U2 - 10.1016/j.yjmcc.2005.06.019

DO - 10.1016/j.yjmcc.2005.06.019

M3 - Article

C2 - 16427650

AN - SCOPUS:31444455757

VL - 40

SP - 205

EP - 212

JO - Journal of Molecular and Cellular Cardiology

JF - Journal of Molecular and Cellular Cardiology

SN - 0022-2828

IS - 2

ER -